Gaudric A, Massin-Korobelnik P
Service d'Ophtalmologie, Hôpital Lariboisière, Paris, France.
Diabete Metab. 1993 Sep-Oct;19(5):422-9.
Macular edema is the main cause of visual impairment in diabetic patients. It occurs in about 10% of the diabetic population and in 30% of patients with up to twenty years of diabetes. Macular edema usually progress very slowly. Several studies have shown that almost 50% of the eyes affected displayed no change in vision during a two-year follow-up. Macular edema may spontaneously resolve, and probably responds to correction of glycemic and systemic anomalies, thus indicating that it does not require urgent treatment. The treatment of macular edema is based on argon green laser photocoagulation. Extra macular focal photocoagulation delivered to the center of circinate exudates results in exudate resorption and is indicated when ever the exudates enter the macular area. The treatment of cystoid macular edema consists of grid photocoagulation in the perifoveolar area. In most cases, it results in the disappearance of CME and visual stabilization, but rarely in visual improvement.
黄斑水肿是糖尿病患者视力损害的主要原因。它发生在约10%的糖尿病患者中,在病程长达20年的患者中发生率为30%。黄斑水肿通常进展非常缓慢。多项研究表明,在两年的随访期间,几乎50%的受影响眼睛视力没有变化。黄斑水肿可能会自行消退,并且可能对血糖和全身异常的纠正有反应,因此表明它不需要紧急治疗。黄斑水肿的治疗基于氩绿激光光凝。对环形渗出物中心进行黄斑外局部光凝可导致渗出物吸收,当渗出物进入黄斑区时即可进行。黄斑囊样水肿的治疗包括在黄斑小凹周围区域进行格栅样光凝。在大多数情况下,它会导致囊样黄斑水肿消失和视力稳定,但很少能改善视力。